Glucagon like Peptide 1 News and Research

RSS
Diabetes drug dulaglutide may reduce symptoms of depression

Diabetes drug dulaglutide may reduce symptoms of depression

Study reveals mechanisms behind antidepressant effects of diabetes drug

Study reveals mechanisms behind antidepressant effects of diabetes drug

New hope for binge eating and bulimia: GLP-1 drugs could be the key

New hope for binge eating and bulimia: GLP-1 drugs could be the key

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

New weight loss drug may be an effective strategy for preventing or treating high blood pressure

What does the future hold for obesity medication development?

What does the future hold for obesity medication development?

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

GLP-1R agonist liraglutide rapidly improves insulin sensitivity in pre-diabetics, independent of weight loss

GLP-1R agonist liraglutide rapidly improves insulin sensitivity in pre-diabetics, independent of weight loss

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

Combination therapy of dapagliflozin and semaglutide shows superior efficacy in type 2 diabetes management

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

New insights into how anti-obesity drugs could help prevent kidney disease

New insights into how anti-obesity drugs could help prevent kidney disease

A class of diabetes medications may reduce the risk of colorectal cancer

A class of diabetes medications may reduce the risk of colorectal cancer

Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity

Groundbreaking studies indicate Semaglutide and Tirzepatide may reduce alcohol consumption in individuals with obesity

Exploring 'food noise': Study sheds light on eating thoughts and obesity treatment breakthroughs

Exploring 'food noise': Study sheds light on eating thoughts and obesity treatment breakthroughs

New study links DNA methylation in GLP1R gene to obesity without metabolic disorders

New study links DNA methylation in GLP1R gene to obesity without metabolic disorders

Citrus compounds show zesty promise in type 2 diabetes management

Citrus compounds show zesty promise in type 2 diabetes management

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.